Literature DB >> 9888392

A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness.

N al-Jandal1, G J Farrar, A S Kiang, M M Humphries, N Bannon, J B Findlay, P Humphries, P F Kenna.   

Abstract

More than 100 mutations within the rhodopsin gene have been found to be responsible for some forms of retinitis pigmentosa, a progressive retinal degeneration characterized by night blindness and subsequent disturbance of day vision that may eventually result in total blindness. Congenital stationary night blindness (CSNB) is an uncommon inherited retinal dysfunction in which patients complain of night vision difficulties of a nonprogressive nature only and in which generally there is no involvement of day vision. We report the results of molecular genetic analysis of an Irish family segregating an autosomal dominant form of CSNB in which a previously unreported threonine-to-isoleucine substitution at codon 94 in the rhodopsin gene was found to segregate with the disease. Computer modeling suggests that constitutive activation of transducin by the altered rhodopsin protein may be a mechanism for disease causation in this family. Only two mutations within the rhodopsin gene have been previously reported in patients with congenital stationary night blindness, constitutive activation also having been proposed as a possible disease mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888392     DOI: 10.1002/(SICI)1098-1004(1999)13:1<75::AID-HUMU9>3.0.CO;2-4

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  27 in total

Review 1.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

2.  Light/dark translocation of alphatransducin in mouse photoreceptor cells expressing G90D mutant opsin.

Authors:  Zack A Nash; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  Congenital stationary night blindness associated with mutations in GRM6 encoding glutamate receptor MGluR6.

Authors:  E O'Connor; L E Allen; K Bradshaw; J Boylan; A T Moore; D Trump
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

5.  Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association.

Authors:  Michael F Marmor; Christina Zeitz
Journal:  Doc Ophthalmol       Date:  2018-07-26       Impact factor: 2.379

6.  Congenital stationary night blindness and a "Schubert-Bornschein" type electrophysiology in a family with dominant inheritance.

Authors:  S A Kabanarou; G E Holder; F W Fitzke; A C Bird; A R Webster
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 7.  Constitutively active rhodopsin and retinal disease.

Authors:  Paul Shin-Hyun Park
Journal:  Adv Pharmacol       Date:  2014

Review 8.  Finding and interpreting genetic variations that are important to ophthalmologists.

Authors:  Edwin M Stone
Journal:  Trans Am Ophthalmol Soc       Date:  2003

9.  Structural role of the T94I rhodopsin mutation in congenital stationary night blindness.

Authors:  Ankita Singhal; Ying Guo; Milos Matkovic; Gebhard Schertler; Xavier Deupi; Elsa Cy Yan; Joerg Standfuss
Journal:  EMBO Rep       Date:  2016-07-25       Impact factor: 8.807

10.  Mutation screening and haplotype analysis of the rhodopsin gene locus in Japanese patients with retinitis pigmentosa.

Authors:  Yuichiro Ando; Masayuki Ohmori; Hideki Ohtake; Kuniyo Ohtoko; Shigeru Toyama; Ron Usami; Aya O'hira; Hiromi Hata; Kenji Yanashima; Seishi Kato
Journal:  Mol Vis       Date:  2007-06-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.